NCT03391700

Brief Summary

Investigators assess and compare postoperative sore throat and hoarseness in the group maintaining moderate relaxation and deep relaxation during operation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
206

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 5, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 14, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 14, 2019

Completed
Last Updated

June 26, 2018

Status Verified

June 1, 2018

Enrollment Period

12 months

First QC Date

November 9, 2017

Last Update Submit

June 22, 2018

Conditions

Keywords

muscle relaxant

Outcome Measures

Primary Outcomes (1)

  • Overall incidence of postoperative sore throat

    The overall cumulative incidence of postoperative sore throat is assessed in the 24-hr evaluation period

    Within 24 hrs after operation

Secondary Outcomes (4)

  • The incidence of postoperative sore throat

    At 1,6, and 24 hrs after operation

  • The severity of postoperative sore throat

    At 1,6, and 24 hrs after operation

  • Incidence and severity of postoperative hoarseness

    At 1,6, and 24 hrs after operation

  • Postoperative analgesic consumption

    Within 24 hrs after operation

Study Arms (2)

Moderate muscle relaxation

ACTIVE COMPARATOR

Rocuronium is administered to maintain moderate relaxation during operation. This is conventional muscle relaxation level of this institute.

Drug: Rocuronium(moderate)

Deep muscle relaxation

EXPERIMENTAL

Rocuronium is administered to maintain deep relaxation during operation.

Drug: Rocuronium(deep)

Interventions

In the group with deep relaxation during surgery, rocuronium is given by continuous infusion (0.6 mg/kg/h).

Deep muscle relaxation

In the group with deep relaxation during surgery, rocuronium is given by bolus dose(0.15mg/kg) induced a train of four count of 1-2.

Moderate muscle relaxation

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Requirement for mechanical ventilation under general anesthesia

You may not qualify if:

  • Hoarseness and sore throat existed before surgery
  • Upper respiratory infection
  • Known or predicted difficult airway
  • Liver, renal disease
  • Requirement of postoperative ventilator care
  • the operation within 2hrs
  • Laparoscopic surgery
  • Other positions except supine during surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jee-Eun Chang

Seoul, 07061, South Korea

RECRUITING

MeSH Terms

Conditions

PharyngitisMuscle Hypotonia

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jee-eun Chang, M.D

    SMG-SNU Boramae Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jee-Eun Chang, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

November 9, 2017

First Posted

January 5, 2018

Study Start

August 1, 2017

Primary Completion

July 14, 2018

Study Completion

August 14, 2019

Last Updated

June 26, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations